EUROPEAN NEUROPSYCHOPHARMACOLOGY
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 293
-
Social cognition in first-degree relatives of patients with bipolar disorder: A meta-analysisBora, Emre / Özerdem, Ayşegül et al. | 2017
- 301
-
EEG connectivity between the subgenual anterior cingulate and prefrontal cortices in response to antidepressant medicationIseger, Tabitha A. / Korgaonkar, Mayuresh S. / Kenemans, J. Leon et al. | 2017
- 313
-
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticityBontempi, Leonardo / Savoia, Paola / Bono, Federica et al. | 2017
- 325
-
Partial agonism at the α7 nicotinic acetylcholine receptor improves attention, impulsive action and vigilance in low attentive ratsHayward, Andrew / Adamson, Lisa / Neill, Joanna C. et al. | 2017
- 336
-
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal–amygdala–insular circuitZubedat, Salman / Akirav, Irit et al. | 2017
- 350
-
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up studySanchez-Moreno, Jose / Bonnín, Caterina / González-Pinto, Ana et al. | 2017
- 360
-
CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?Schartner, Christoph / Ziegler, Christiane / Schiele, Miriam A. et al. | 2017
- 372
-
Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humansBosch, Oliver G. / Havranek, Michael M. / Baumberger, Andrea et al. | 2017
- 383
-
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonismAringhieri, Stefano / Kolachalam, Shivakumar / Gerace, Claudio et al. | 2017
- 399
-
Noradrenaline transporter blockade increases fronto-parietal functional connectivity relevant for working memoryHernaus, Dennis / Casales Santa, Marta Ma / Offermann, Jan Stefan et al. | 2017
- 411
-
The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanismBjörkholm, Carl / Marcus, Monica M. / Konradsson-Geuken, Åsa et al. | 2017
- 418
-
Evidence-based national suicide prevention taskforce in Europe: A consensus position paperZalsman, Gil / Hawton, Keith / Wasserman, Danuta et al. | 2017
- iii
-
Contents| 2017
- S521
-
Abstracts of the 30th ECNP Congress| 2017
- S521
-
Endophenotypes in schizophreniaFreedman, R. et al. | 2017
- S522
-
From genes to clinical phenotype in ADHD across the lifespanFranke, B. et al. | 2017
- S525
-
Exome or whole genome sequencing in bipolar disorderKato, T. et al. | 2017
- S526
-
When she's gone: oxytocin reverses partner loss-induced passive stress copingBosch, O. et al. | 2017
- S527
-
The role of serotonin and reward circuit architecture in oxytocin promoted social cognition: neuroimaging insightsFrokjaer, V.G. et al. | 2017
- S528
-
Re-examining the antidepressant potential and mechanisms of isofluraneRantamäki, T. et al. | 2017
- S530
-
Synaptic basis of cocaine addictionPascoli, V. et al. | 2017
- S531
-
Habit formation in humans with cocaine addictionErsche, K.D. et al. | 2017
- S533
-
SERT gene variation and response to exposure therapy in agoraphobiaSchruers, K. et al. | 2017
- S534
-
From candidate gene to (epi)genome-wide analysis of therapy response in adult anxiety disordersDomschke, K. / Ziegler, C. / Richter, J. et al. | 2017
- S536
-
Genome-wide association analysis implicates microRNAs in bipolar affective disorderForstner, A.J. / Maaser, A. / Sumer, S. et al. | 2017
- S537
-
Ketamine restores changes in glutamate release, dendrite morphology and BDNF trafficking in the hippocampus of rats vulnerable to chronic mild stressTornese, P. / Musazzi, L. / Sala, N. et al. | 2017
- S538
-
A novel approach to map induced activation of neuronal networks using chemogenetics and functional neuroimagingRoelofs, T.J.M. / Verharen, J.P.H. / Van Tilborg, G.A.F. et al. | 2017
- S539
-
Role of the matricellular protein hevin in drug responseMongredien, R. / Yau, A. / Rezai Amin, S. et al. | 2017
- S540
-
Emerging novel psychoactive substances in EuropeTorrens, M. et al. | 2017
- S541
-
Behavioural toxicology and metabolomics of novel psychoactive substances (NPS) in controlled human studiesRamaekers, J. et al. | 2017
- S542
-
The KEEP-WELL trial (NCT02414932) – ketamine for depression relapse prevention following ECTMcLoughlin, D. / Finnegan, M. / Ryan, K. et al. | 2017
- S543
-
The concept of resilience: definition and measurementKane, J.M. et al. | 2017
- S544
-
Dopamine and resilience in schizophrenia: a review and clinical implicationsUchida, H. / Suzuki, T. / Yagi, G. et al. | 2017
- S545
-
Glucocorticoid receptor-dependent signalling in astrocytes as target of opioid actionBarut, J. / Skupio, U. / Tertil, M. et al. | 2017
- S546
-
Mineralocorticoid receptor and cognitive function in major depressionKaczmarczyk, M. / Otte, C. / Wingenfeld, K. et al. | 2017
- S547
-
Acute psychosocial stress impacts the hemodynamic response latency: a novel brain-phenotype of acute stress and GR-sensitivityElbau, I. / Bruecklmeier, B. / Arloth, J. et al. | 2017
- S548
-
Can we weaken or rewrite maladaptive alcohol memories via reconsolidation?Das, R. / Walsh, K. / Lawn, W. et al. | 2017
- S549
-
Sex differences in neuroplasticity and neurosteroids effectsGarcia-Segura, L.M. / Melcangi, R.C. et al. | 2017
- S550
-
Clinical studies on comorbidity of internet gaming disorders with mood, anxiety and personality disordersWeinstein, A. et al. | 2017
- S551
-
Aerobic exercise interventions as feasible and effective interventions for schizophreniaMalchow, B. et al. | 2017
- S554
-
Understanding complex inputs to an abnormal circuitry in the trisynaptic pathway in schizophreniaBenes, F.M. et al. | 2017
- S556
-
Brain-computer interface using high-density intracortical microelectrode arrays for robotic limb control and reliable communicationJarosiewicz, B. et al. | 2017
- S558
-
Clinical studies of epistasis at the level of cognition and other functional aspects of psychotic illnessNicodemus, K. et al. | 2017
- S559
-
Childhood trauma in bipolar disorder: familial continuity and individual mediators for severityEtain, B. et al. | 2017
- S560
-
Childhood trauma and structural and functional brain mechanisms linked to psychopathologyAas, M. et al. | 2017
- S561
-
Ethical considerations about recommending technology for patients with bipolar illnessBauer, M. / Glenn, T. / Bauer, R. et al. | 2017
- S562
-
EEG neurofeedback in ADHD: new metaanalyses and multicentre trialsBrandeis, D. et al. | 2017
- S563
-
Oligodendroglial myelin in cortical circuits: functional roles beyond the axonKole, M. et al. | 2017
- S564
-
Intra-cortical myelination during adolescence: linking MRI networks with gene transcription profilesWhitaker, K. / Vértes, P. / Romero-Garcia, R. et al. | 2017
- S565
-
Fragile X syndrome: from molecular pathology to therapyBardoni, B. / Maurin, T. et al. | 2017
- S566
-
Relationships between inflammation, elevated body mass index, and depressive relapse in bipolar disorderBond, D. / Andreazza, A.C. / Hughes, J. et al. | 2017
- S568
-
Effects of antidepressants on sexual function and satisfaction – implications for drug developmentClayton, A. et al. | 2017
- S569
-
Anxiolytic, hypnotic and analgesic properties of melatonin MT2 receptor partial agonistsGobbi, G. / Lopez-Canul, M. / Ochoa-Sanchez, R. et al. | 2017
- S570
-
Current melatonergic therapies for insomniaZisapel, N. et al. | 2017
- S575
-
Synthetic cannabinoids: clinical aspects and therapy optionsFattore, L. et al. | 2017
- S577
-
PDE7B, NMBR and EPM2A variants and schizophrenia: a case-control and pharmacogenetics studyKim, H. / Jun, T.Y. et al. | 2017
- S578
-
Financial hardship may trigger migraine through circadian dysregulation – a possible role for the CLOCK geneBaksa, D. / Gonda, X. / Edes, A. et al. | 2017
- S579
-
Genome-wide gene-based tests replicate the association of the SORCS3 gene with neuroticismEszlari, N. / Millinghoffer, A. / Petschner, P. et al. | 2017
- S580
-
Gene expression biomarkers related to auditory hallucinations in peripheral blood of patients with schizophreniaGilabert-Juan, J. / Lopez-Campos, G. / Sebastia-Ortega, N. et al. | 2017
- S582
-
Meta-analysis of CYP2C19 association with efficacy and side effects of citalopram and escitalopramFabbri, C. / Tansey, K. / Perlis, R. et al. | 2017
- S583
-
A new target for focusing on neurocognitive symptoms in depression: ATP6V1B2 rs1106634 is associated with hippocampal deficit and lifetime depressionGonda, X. / Eszlari, N. / Baksa, D. et al. | 2017
- S585
-
Genetic association with suicidal ideation in patients with acute coronary syndromeKang, H.J. / Bae, K.Y. / Kim, S.W. et al. | 2017
- S586
-
Translational identification of transcriptional signatures of major depression and antidepressant responseHervé, M. / Bergon, A. / Le Guisquet, A.M. et al. | 2017
- S587
-
Gene expression in the brain of rats with increased aggression and signs of cognitive deficits caused by the early social isolationKrupina, N.A. / Zubkov, E.A. / Zorkina, Y.A. et al. | 2017
- S588
-
A brainstem structural intermediate phenotype of CYP2C19 polymorphismStingl, J.C. / Paul, A. / Steffens, M. et al. | 2017
- S589
-
Assessment of DNA methylation status in HERV-K sequences in patients with first-episode schizophreniaMisiak, B. / Stramecki, F. / Szmida, E. et al. | 2017
- S590
-
Association between polymorphisms of the PCDH15 gene and schizophrenia in Korean populationChoi, Y. / Kang, W. / Kim, E. et al. | 2017
- S591
-
Reduced glutamatergic metabolism in the anterior cingulate cortex in carriers of the Met-allele of the BDNF Val66Met polymorphismMartens, L. / Fensky, L. / Colic, L. et al. | 2017
- S593
-
Distribution of C4 copy number variations in bipolar disorder, schizophrenia and systemic lupus erythematosusMariaselvam, C.M. / Sundaresh, A. / Bennabi, M. et al. | 2017
- S595
-
Genetic and clinical evidence of mitochondrial dysfunction in autism spectrum disorder and intellectual disabilityValiente Pallejà, A. / Muntané, G. / Cortés, M. et al. | 2017
- S597
-
Increased DNA methylation in the parvalbumin gene promoter in schizophrenia – relationship with symptoms and drug treatmentReynolds, G.P. / Fachim, H. / Zeng, L. et al. | 2017
- S598
-
Maternal depression during pregnancy: implications for baby epigenetic signature and stress response systemFarrell, C. / O'Leary, N. / Jairaj, C. et al. | 2017
- S599
-
Histamine H1 receptor level in peripheral blood lymphocytes of schizophrenic patients as possible diagnostic marker of olanzapine treatment efficacyZabotina, A.M. / Taraskina, A.E. / Nasyrova, R.F. et al. | 2017
- S600
-
Incomplete replication of association between DRD2 C957T and cognition in schizophreniaSpitoni, S. / Drago, A. et al. | 2017
- S602
-
A possible GABAergic biomarker for adult autism spectrum disorderMcCracken, J. et al. | 2017
- S603
-
In vivo real-time monitoring of corticostriatal synaptic plasticityCordeiro, C.A. / Koster, T. / Kuhl, L. et al. | 2017
- S604
-
Validating a novel protocadherin 9 conditional knockout mouse model to study sensory cortex functioningHornix, B.E. / Kat, R. / Havekes, R. et al. | 2017
- S605
-
Cerebellum and attention to the eyes in autismLaidi, C. / Boisgontier, J. / Chakravarty, M. et al. | 2017
- S606
-
X-linked PCDH19 protein regulates cortical and hippocampal development, seizure susceptibility, cognition and autism-related behaviorsCwetsch, A. / Perlini, L. / Bassani, S. et al. | 2017
- S607
-
FMRI correlates of social cognition in attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and comorbid conditionIlzarbe, D. / Lukito, S. / O'Daly, O. et al. | 2017
- S608
-
MGlu2 as a novel target underling sex-differences in a ventral dentate gyrus (vDG)-medial amygdala (MeA) circuit controlling social behaviour: importance of early life experiencesNasca, C. / Bigio, B. / Cates, H. et al. | 2017
- S609
-
Dexamethasone upregulates levels of proapoptotic proteins proBDNF and cleaved caspase-3 in the frontal cortex and the hippocampus of neonatal ratsBulygina, V. / Kalinina, T.S. / Lanshakov, D.A. et al. | 2017
- S610
-
GABA-A α5 receptor potentiation in preadolescence prevents hyporeactivity to amphetamine induced by prenatal lipopolysaccharide treatment in rat femalesBatinic, B. / Santrač, A. / Jančić, I. et al. | 2017
- S611
-
Inhibition of DYRK1A overdosage restores cognition in Down syndrome models through DYRK1A-interaction with major players of synaptic transmissionHerault, Y. / Nguyen, T. / Duchon, A. et al. | 2017
- S612
-
Survival effect of embryonic proteoglycans in Alzheimer's disease via simultaneous activation of neurogenesis and angiogenesis in adult brainYenkoyan, K. / Davtyan, T. / Fereshetyan, K. et al. | 2017
- S613
-
Perinatal and early childhood prognosis factors in children with neurodevelopmental disordersKobylinska, L. / Anghel, C. / Rad, F. et al. | 2017
- S615
-
Knockout of the glucocorticoid receptor in astrocytes alters contextual aversive memory in miceSkupio, U. / Kudla, L. / Marut, L. et al. | 2017
- S617
-
Serum VGF levels were significantly changed in mental disorders and may aid the diagnosisYuan, Y. / Chen, S. / Jiang, H. et al. | 2017
- S619
-
Lithium treatment and thyroid function – a retrospective study in patients with unipolar depression, bipolar and schizoaffective disordersSobreira, G. / Oliveira, J. et al. | 2017
- S620
-
The effects of hypocalcaemia on prolactinoma cell populationsMolnar, Z. / Radács, M. / Rácz, L. et al. | 2017
- S621
-
Testosterone application modulates resting-state connectivity in emotion regulation networkVotinov, M. / Wagels, L. / Hoffstaedter, F. et al. | 2017
- S622
-
Peroxiredoxin-1 and peroxiredoxin-3 as indicators of sickness behaviour in patients with varying levels of depression severityOgłodek, E.A. / Just, M.J. / Just, K. et al. | 2017
- S623
-
Mechanism of cortisol production in adrenal cortical cells under the non-stress and stress conditions: role of cyclic AMP and calcium in vitro studyKuwabara, N. / Kurihara, T. / Yoshie, M. et al. | 2017
- S625
-
A study of mechanisms behind extreme aggression: the possible existence of functional signaling mechanisms modulated by ACTH IgGVærøy, H. / Adori, C. / Legrand, R. et al. | 2017
- S626
-
Variation in cytokines and C-reactive protein in different psychiatric disordersSakai, Y. / Iversen, V.C. / Groven, N.H. et al. | 2017
- S627
-
History of depression is associated with neuropsychiatric symptoms and augmented inflammatory markers in a cross sectional study on obese patientsOriolo, G. / Huet, L. / Dexpert, S. et al. | 2017
- S628
-
Selective inhibition of purinergic 2X7 receptors elicits antidepressant-like effect in chronic mild stress model in rats: role of innate immunityAricioglu, F. / Sahin Ozkartal, C. / Bastaskin, T. et al. | 2017
- S630
-
Central and peripheral effects of lipopolysaccharide administration in ratsWadolowska, A. / Myslinska, D. / Podlacha, M. et al. | 2017
- S631
-
Fractalkine alters synaptic activity of rat principal cells in the basolateral amygdalaSowa, J.E. / Tokarski, K. / Hess, G. et al. | 2017
- S632
-
The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolitesMalmei Aarsland, T.I. / Leskauskaite, I. / Midttun, Ø. et al. | 2017
- S633
-
IgG antibodies with nuclease activity in serum of patients with schizophreniaErmakov, E. / Smirnova, L. / Ivanova, S. et al. | 2017
- S634
-
Inflammation in schizophrenia: implications for pathophysiology and treatmentCastanheira, L. / Ferreira, C. / Ferreira, L. et al. | 2017
- S635
-
Β2-microglobulin: a biomarker for bipolar disorder and schizophrenia?Sayous, R. / Manier, C. / Hamdani, N. et al. | 2017
- S636
-
Prolyl endopeptidase is involved in the degradation of neural cell adhesion moleculesJaako, K. / Noortoots, A. / Aonurm-Helm, A. et al. | 2017
- S637
-
Chronic stress triggers Tau pathology through autophagy inhibition and induction of stress granulesSilva, J. / Rodrigues, S. / Marques, M. et al. | 2017
- S639
-
Effect of a single dose of methylphenidate on cognition in adults with attention deficit hyperactivity disorders and predictive therapeutic responseErtle, S. / Vanoli, L. / Erb, A. et al. | 2017
- S641
-
Contrasting effects by blocking orexin and NMDA receptors in telemetric EEG recordings in ratsFerger, B. / Voehringer, P. / Raith, H. et al. | 2017
- S642
-
5-HT1A biased agonists induce different hemodynamic responses: a pharmacological MRI studyVidal, B. / Bolbos, R. / Redouté, J. et al. | 2017
- S643
-
Exploration of the concept of 5-HT1A receptor biased agonists: a multimodal imaging studyVidal, B. / Fieux, S. / Redouté, J. et al. | 2017
- S645
-
Stevens-Johnson syndrome induced by sodium valproate – a case reportNascimento, S. / Freitas, F. / Pereira, D. et al. | 2017
- S647
-
Effects of chronic administration of memantine on okadaic acid induced changes in hippocampus and medial septal nucleusBeselia, G. / Dashniani, M. et al. | 2017
- S648
-
Resveratrol prevents schizophrenia-like behaviour and neural plasticity abnormalities induced by maternal immune activationMoura, N. / Pombo, T. / Ferreira, F. et al. | 2017
- S649
-
Neuronal and peripheral markers of plasticity dynamics, change concomitantly after sub-anesthetic dose of ketamine in humansColic, L. / McDonnell, C. / Li, M. et al. | 2017
- S650
-
Serum concentrations of iNos and IL-33 in depressed patients with a history of suicide attemptsOgłodek, E.A. / Just, M.J. / Moś, D.M. et al. | 2017
- S651
-
Glutamate levels measured by glutamate voltammetry in the rat prefrontal cortex after treatment with N-methyl-D-aspartate receptor antagonistsIonescu, I. / Allers, K. / Arban, R. et al. | 2017
- S652
-
MTOR signaling is involved in the promnesic effects of both 5HT6R agonist and antagonistAsselot, R. / Dauphin, F. / Leger, M. et al. | 2017
- S653
-
Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphismsArnaiz, A. / Zumarraga, M. / Olivas, O. et al. | 2017
- S654
-
Effect of brain-derived neurotrophic factor treatment on behavior and brain serotonin system in tumor necrosis factor-α knockout miceBazovkina, D. / Kulikova, E. / Bazhenova, E. et al. | 2017
- S655
-
The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomniaBrooks, S. / Siebenga, P. / Zuiker, R. et al. | 2017
- S656
-
Evaluation of the effects of etifoxine (100 mg) and lorazepam (2 mg) on alertness and cognitive functions in elderly subjectsDeplanque, D. / Machuron, F. / Waucquier, N. et al. | 2017
- S657
-
Modified cinnamic acid derivatives as effective mito- and neuroprotective substancesNeganova, M. / Semenov, V. / Semenova, M. et al. | 2017
- S658
-
Behavioural and hippocampal morphological changes induced by short ketamine treatment in a genetic rat model displaying depressive-like behaviourTreccani, G. / Ardalan, M. / Liebenberg, N. et al. | 2017
- S659
-
Endogenous opioids scale social threat learning in humansHaaker, J. / Yi, J. / Petrovic, P. et al. | 2017
- S660
-
Lumateperone (ITI-007): a novel investigational agent with broad therapeutic potential across multiple neuropsychiatric disordersVanover, K.E. / O'Gorman, C. / Correll, C.U. et al. | 2017
- S661
-
Efficacy of bremelanotide in The RECONNECT StudiesClayton, A. / Lucas, J. / Jordan, R. et al. | 2017
- S662
-
Aβ1-42 impairs mGluR5-gated spike timing-dependent long-term potentiation by disrupting CB1 receptorsLee, J. / Kwag, J.H. et al. | 2017
- S663
-
Endocannabinoid neurotransmission inhibits the formation of nitric oxide in the bed nucleus stria terminalis during acute restraint stress in ratsGomes-de-Souza, L. / Oliveira, L.A. / Benini, R. et al. | 2017
- S664
-
Impact of antipsychotic drugs on neuronal model cells proteomeJankowska, U. / Skupien-Rabian, B. / Swiderska, B. et al. | 2017
- S666
-
Brain-derived neurotrophic factor Val66Met genotype interacts with young-adult stress in neurotransmitter regulation of prepulse inhibition in miceVan den Buuse, M. / Lee, J.J.W. / Jaehne, E. et al. | 2017
- S667
-
Rats exposed to maternal depression and antidepressant treatment during development show sex differences in social behaviorHouwing, D.J. / Ramsteijn, A.S. / Staal, L. et al. | 2017
- S668
-
Scopolamine hydrobromide is indeed a proper memory impairments inductor in micePodkowa, A. / Sałat, K. / Podkowa, K. et al. | 2017
- S669
-
Assessments of the behavioral disorder in the photothrombotic stroke model mouseIto, Y. / Tsuboi, M. / Iguchi, C. et al. | 2017
- S670
-
Analgesic and anti-inflammatory effects of a novel N-pyrrolylcarboxylic acid derivativeZlatanova, H. / Vladimirova, S. / Kandilarov, I. et al. | 2017
- S671
-
Reinforcing properties of the glutamate receptors antagonists and karyotypic stability in ratsBarinova, I. / Potapkin, A.M. / Lebedev, A.A. et al. | 2017
- S673
-
The trace amine-associated receptor 1 modulates nicotine behavioural effectsSukhanov, I. / Dorotenko, A. / Dolgorukova, A. et al. | 2017
- S675
-
Altered serotonergic gene expression in the brain regions of male mice with anxiety/depression-like state and pathology of aggressive behaviourSmagin, D.A. / Kovalenko, I.L. / Galyamina, A.G. et al. | 2017
- S677
-
Reduced aggression, social impairments, and cognitive inflexibility in neuronal nitric oxide (Nos1) knockdown miceO'Leary, A. / Freudenberg, F. / Candemir, E. et al. | 2017
- S678
-
Abnormality of social behavior and dysfunction of autism related gene expression developing under chronic social defeat stress in male miceKudryavtseva, N.N. / Kovalenko, I.L. / Smagin, D.A. et al. | 2017
- S679
-
Comparing models of autism spectrum disorder based on pre- and postnatal valproate exposure: behavioral and histological assessmentGedzun, V. / Dubynin, V. / Malyshev, A. et al. | 2017
- S680
-
Age-related changes in negative affect and cognitive performance in Sprague-Dawley rats: possible role of the cell fate regulator FADDHernández-Hernández, E. / García-Fuster, M.J. et al. | 2017
- S682
-
Gender specific behavioral alterations are associated with gut dysbiosis in mice exposed to multifactorial early-life adversityRincel, M. / Aubert, P. / Chevalier, J. et al. | 2017
- S683
-
Behavioural and peripheral effects of the central nucleus of the amygdala stimulation are more pronounced in high responder ratsRuciński, J. / Myslinska, D. / Wadolowska, A. et al. | 2017
- S684
-
Antinociceptive, antiallodynic and antihyperalgesic activities of NLX-112 in acute, tonic and neuropathic pain models in miceFurgała, A. / Sałat, K. / Kołaczkowski, M. et al. | 2017
- S685
-
50kHz ultrasonic vocalization as a marker of positive affect in mania models: mixed effects induced by ouabainWendler, E. / Souza, C. / Dornellas, A. et al. | 2017
- S686
-
Pharmacological inhibition of gut leakiness prevents the long-term effects of early-life stress in ratsDarnaudéry, M. / Rincel, M. / Minni, A. et al. | 2017
- S687
-
Mesenchymal stem cells secretome: a new therapeutic tool for Parkinson's disease regenerative medicine?Mendes-Pinheiro, B. / Teixeira, F.G. / Anjo, S. et al. | 2017
- S688
-
Differential role of NMDA receptor subunits in the development of PTSD-like symptomsBiro, L. / Sipos, E. / Miskolczi, C. et al. | 2017
- S689
-
Activation of the nigrostriatal dopaminergic pathway increases prepulse-inhibition of the startle response in female but not in male Long Evans ratsCasado, A. / Baerentzen, S. / Kjaerby, C. et al. | 2017
- S690
-
Down syndrome model characterization: adult and post-natal neurogenesis enhancement with selective α5 GABA-A modulator and recombinant human IGF-1Albac, C. / Bartesaghi, R. / Créau, N. et al. | 2017
- S691
-
Transcutaneous vagus nerve stimulation for treatment-resistant depression – the first experiences: a pilot studyAntosik-Wójcińska, A.Z. / Kaczmarczyk, M. / Swięcicki, Ł. et al. | 2017
- S692
-
Altered functional connectivity of the amygdala during humor processing in patients with schizophreniaBerger, P. / Bitsch, F. / Nagels, A. et al. | 2017
- S693
-
Treatment-resistant depression in schizophrenia: clinical response predictors of repetitive transcranial magnetic stimulation (rTMS)Maslenikov, N. / Tsukarzi, E.E. / Mosolov, S.N. et al. | 2017
- S695
-
Social cognition in schizophrenia patients and their siblings: the role of insulaCaldiroli, A. / Buoli, M. / Van Haren, N. et al. | 2017
- S696
-
Increased glutamate/GABA ratio links the autism and schizophrenia spectra through a social disorganisation trait phenotypeFord, T.C. / Nibbs, R. / Crewther, D.P. et al. | 2017
- S697
-
Correlation between depression and volume of hippocampal subfields in the elderly with subclinical depressionKim, S.K. / Lee, J.G. et al. | 2017
- S698
-
Glutamate levels in the medial prefrontal cortex during pregnancyLe Melledo, J.M. / Ghuman, A. / McEwen, A. et al. | 2017
- S700
-
Superficial white matter integrity in autism spectrum disordersD'Albis, M.A. / Guevara, P. / Guevara, M. et al. | 2017
- S701
-
White matter connectivity related to amisulpride treatment response in patients with schizophreniaKim, J.H. / Choi, T.K. / Lee, S.H. et al. | 2017
- S702
-
Deviations from the physiological, ultradian glucocorticoid rhythm are accompanied by altered behavioural and fMRI responses to emotional stimulationKalafatakis, K. / Russell, G.M. / Harmer, C.J. et al. | 2017
- S703
-
High angular resolution diffusion imaging correlates of depression in Parkinson's disease: a connectometry studyMayeli, M. / Sobhani, S. / Ghazi Sherbaf, F. et al. | 2017
- S704
-
Effects of natural medicinal on emotional brain responseColic, L. / Martens, L. / Fensky, L. et al. | 2017
- S705
-
Effects of natural medicinal on amygdala-centered resting state functional connectivityColic, L. / Fan, Y. / Fensky, L. et al. | 2017
- S706
-
Meditation-associated change in the functional connectivity of the insulaJang, J.H. / Kim, J.H. / Yun, J.Y. et al. | 2017
- S707
-
Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopramSchrantee, A. / Lucassen, P. / Booij, J. et al. | 2017
- S708
-
Monoamine oxidase A distribution volume as a correlate for electroconvulsive therapy – preliminary resultsBaldinger-Melich, P. / James, G.M. / Gryglewski, G. et al. | 2017
- S709
-
Tryptophan catabolism affects the neural correlates of mood-congruent processing biases in bipolar depressionVai, B. / Riberto, M. / Ghiglino, D. et al. | 2017
- S710
-
Investigation of cerebral cortex hemodynamic activations using fNIRS during mind reading task in subjects with autism spectrum disorderDuman, B. / Kale, E. / Yenihayat, I. et al. | 2017
- S711
-
Brain responses in the theory of mind network are modulated by intention type in schizophreniaBitsch, F. / Berger, P. / Nagels, A. et al. | 2017
- S712
-
Assessment of the myelination of brain structures in patients with schizophrenia using the MRI methodParshukova, D. / Smirnova, L.P. / Seregin, A.A. et al. | 2017
- S713
-
Do metabolic parameters of posterior cingulate gyrus in multiple sclerosis correlate with the duration of the disease?Zacharzewska-Gondek, A. / Gondek, T.M. / Pokryszko-Dragan, A. et al. | 2017
- S715
-
Novel insights into the neurometabolic homeostasis of cocaine addiction: aberrant glutamatergic mechanisms in the nucleus accumbensEngeli, E. / Hock, A. / Zoelch, N. et al. | 2017
- S716
-
A multicenter positron emission tomography study of GABA receptor availability in adults with autismAndersson, M. / Horder, J. / Mendez, M. et al. | 2017
- S717
-
Evolution of default-mode network alteration in OCD-patients following a cognitive behavioral therapyTezenas, C. / Morgièvre, M. / Mallet, L. et al. | 2017
- S718
-
A novel social perception task for testing the social interaction model in pharmaco-fMRI protocols with selective serotonin reuptake inhibitorsBeinhölzl, N. / Naor, N. / Okon-Singer, H. et al. | 2017
- S719
-
Reduced gray matter in subcortical brain regions in MDD: preliminary results of an ultra-high field 7 Tesla MRI StudyVanicek, T. / Seiger, R. / Auer, B. et al. | 2017
- S720
-
Effects of cardiovascular fitness on hippocampal volume and vasculature in young adultsKaiser, A. / Schrantee, A. / Solleveld, M.M. et al. | 2017
- S721
-
Does brain magnetic resonance spectroscopy allow the detection of metabolite changes during immunomodulatory therapy in multiple sclerosis?Gondek, T.M. / Zacharzewska-Gondek, A. / Pokryszko-Dragan, A. et al. | 2017
- S722
-
Response inhibition in misophoniaEijsker, N. / Schröder, A. / Van Wingen, G. et al. | 2017
- S723
-
Hormone and menstrual cycle effects on sleep spindle parameters in oral contraceptive users and controlsUjma, P. / Kristóf, E. / Bódizs, R. et al. | 2017
- S724
-
Etanercept treatment reverses the impaired spatial and emotional memory functions in different age groups of genetic absence epileptic WAG/Rij ratsUtkan, T. / Demirtaş Şahin, T. / Karson, A. et al. | 2017
- S726
-
Examining cognition across the bipolar/schizophrenia diagnostic spectrumLynham, A.J. / Hubbard, L. / Tansey, K.E. et al. | 2017
- S727
-
Modulation of spatial memory function by the basal forebrain GABAergic neuronsKruashvili, L. / Burjanadze, M. / Chighladze, M. et al. | 2017
- S728
-
Changes in EEG markers by TAK-063 in subjects with stable schizophrenia have different temporal relationships with changes in working memoryMacek, T.A. / McCue, M. / Xie, J. et al. | 2017
- S729
-
Cognitive functions and signs of leptin resistance in patients with cerebrovascular disease and metabolic syndrome comorbidityKopchak, O. et al. | 2017
- S730
-
Pharmacological inhibition of bone resorption induces cognitive impairment in rats on high fat high fructose diet: metabolic correlationsZhelyazkova-Savova, M. / Gancheva, S. et al. | 2017
- S731
-
Neurocognitive functions in remission vs. psychotic states: a comparative study between bipolar disorder and schizophreniaCeylan, D. / Akdede, B.B. / Bora, E. et al. | 2017
- S732
-
Psychological and neural mechanisms of rotating leadership in teams: the impact of engagement and shared mental modelCasas Klett, T. / Ni, R. et al. | 2017
- S733
-
Social-intellectual deprivation effects on prefrontal cortex functioning and the "Theory of Mind" development – study in GeorgiaMetreveli, M. / Gagoshidze, T. et al. | 2017
- S734
-
Association of sleep quality and neurocognitive dysfunction in patients with depressionBerdzenishvili, E. / Tabagua, S. et al. | 2017
- S736
-
Effects of donepezil on scopolamine-induced cognitive impairment and Alzheimer's disease-like change in quantitative EEG analysis in rhesus monkeysNakako, T. / Iwamura, Y. / Matsumoto, A. et al. | 2017
- S737
-
Personality, stress, and multitaskingVan Schrojenstein Lantman, M. / Hoebregts, V. / Mackus, M. et al. | 2017
- S739
-
Probing translation: investigating the effect of a serotonin 5-HT6 antagonist compound on cognitive performance of aged ratsGyertyán, I. / Ernyei, A.J. / Kozma, K. et al. | 2017
- S740
-
A comparison of assessment of cognitive functioning on phones and tabletsVan de Loo, A.J.A.E. / Jansen, J. / Tiplady, B. et al. | 2017
- S741
-
Social cognition in autism spectrum disorder is associated with brain serotonin transporter availabilityTangen, A. / Andersson, M. / Nyström, K. et al. | 2017
- S742
-
Risk factor gene BIN1 induces late onset Alzheimer disease presymptomatic phenotypes in a BAC transgenic mouse modelMarechal, D. / Daudin, R. / Bourg, N. et al. | 2017
- S743
-
Rapid memory replay of life-like episodic sequence of events precedes their verbal recall from long-term memoryViñals, X. / Rodríguez, I. / Sols-Balcells, I. et al. | 2017
- S744
-
Risk factors for suicide in the late-life depression: age and sex-related differencesKim, J.W. / Lee, Y.S. et al. | 2017
- S746
-
Related factors with patients who didn't come to visits after being referred by primary careMata Sáenz, B. / Muñoz Martinez, V. / Nuevo Fernández, L. et al. | 2017
- S747
-
Prevalence and characteristics of schizophrenia in 1st versus 2nd generation East-African immigrants in Israel – a 30-year retrospective studyEger, G. / Reuven, Y. / Dreiher, J. et al. | 2017
- S748
-
Age-related pharmacotherapy of attention deficit hyperactivity disorder in adults in Slovenia from 2003 to 2015: a population-based studyStuhec, M. / Locatelli, I. et al. | 2017
- S749
-
Comparison of clinical characteristics between single and repeated suicide attempters admitted to emergency roomWon, S. / Lee, S.J. / Chang, S.M. et al. | 2017
- S750
-
Population and socioeconomic factor based assessment of postpartum depression risk in EuropeBaughman, C. / Bonthapally, V. / Arnold, R. et al. | 2017
- S751
-
Mirror-image study of aripiprazole long-acting injectable for the treatment of psychiatric patients attended in community mental health teamLeón Caballero, J. / Córcoles, D. / Gómez-Perez, L. et al. | 2017
- S752
-
Prenatal and postnatal maternal somatic anxiety and hyperactivity symptoms in childrenBolea-Alamanac, B. / Davies, S. et al. | 2017
- S753
-
Low range magnetic field reduces anxiety degree in genetically epilepsy-prone ratsBukia, N. / Kekelia, G. / Butskhrikidze, M. et al. | 2017
- S754
-
Neuropeptide Y and calcitonin gene-related peptide in CSF in Parkinson's disease with comorbid depression versus major depressive disorderMathé, A.A. / Pâlhagen, S. / Svenningsson, P. et al. | 2017
- S755
-
A study of uric acid concentration in bipolar disorder and schizophreniaMalewska, M. / Permoda-Osip, A. / Szeliga-Neyman, A. et al. | 2017
- S756
-
AMPA receptor subunit expression and receptor binding in patients with addiction: a systematic review of postmortem studiesUeno, F. / Matsushita, S. / Tsujii, T. et al. | 2017
- S758
-
Early life stress affects glutamatergic postsynaptic density genes: implications for novel treatment targetsBuonaguro, E.F. / Morley-Fletcher, S. / Avagliano, C. et al. | 2017
- S759
-
The association between suicide attempts and Toxoplasma gondii infectionShim, S. / Jung, H. / Yang, J. et al. | 2017
- S760
-
The role of C1473G polymorphism in mouse tryptophan hydroxylase-2 gene in the response of brain serotonergic system and behavior to short photoperiodBazhenova, E.Y. / Khotskin, N.V. / Sorokin, I.E. et al. | 2017
- S761
-
Relationship between hippocampal subfield volumes and cortisol awakening response parameters in major depressive disorderDoolin, K. / Frodl, T. / O'Keane, V. et al. | 2017
- S762
-
Clinical characterisation of neurexin1 deletions and their role in neurodevelopmental disordersFitzgerald, J. / Al-Shehhi, M. / Lynch, S. et al. | 2017
- S764
-
Learning deficits and hippocampal neurogenesis in rats overexpressing the dopamine transporterBernhardt, N. / Lieser, M. / Edemann Callesen, H. et al. | 2017
- S765
-
Chronic magnesium supplementation increases hippocampal neurogenesis and decreases proliferation in myocardium in ACTH-treated ratsPetrovic, J. / Labudović-Borović, M. / Puškaš, N. et al. | 2017
- S766
-
Ghrelin: a potential role in the physiological adaptations to long term food restriction and nutritional recovery?Duriez, P. / Berreby, E. / Tolle, V. et al. | 2017
- S767
-
Metabolic, endocrine and central alterations in a chronic mouse model of food restrictionMequinion, M. / Duriez, P. / Le Thuc, O. et al. | 2017
- S768
-
Evaluation of the activity of bupropion in a mouse model of posttraumatic stress disorder using forced swim and elevated plus maze testsMalikowska, N. / Sałat, K. et al. | 2017
- S769
-
NS-398 potentiates the antidepressant-like effect of MTEP in mice: involvement of pro-inflammatory cytokine pathways in the brainSowa-Kućma, M. / Misztak, P. / Pańczyszyn-Trzewik, P. et al. | 2017
- S771
-
Behavioral and hormonal effects of vitamin D3 hormone treatment in the adult female rats with experimental model of menopauseFedotova, J. / Pivina, S.G. / Suchko, A.V. et al. | 2017
- S772
-
Mood disorders in the offspring of antenatally depressed mothers in the Northern Finland 1966 Birth Cohort: relationship to parental mental disorderTaka-Eilola, T. / Mäki, P. / Veijola, J. et al. | 2017
- S773
-
Synapse numbers in the infralimbic cortex of rats subjected to long-term stressCsabai, D. / Wiborg, O. / Czéh, B. et al. | 2017
- S774
-
Effect of mTOR silencing in mouse infralimbic cortex on depressive-like behaviourGarro-Martinez, E. / Fullana, N. / Paz, V. et al. | 2017
- S775
-
Autophagy and affective disorders: pharmacological and molecular studiesKara, N. / Luczak, T. / Agam, G. et al. | 2017
- S776
-
Altered hippocampal proteins in depressive-like rats after chronic stress: findings from a proteomic studyLi, X. / Zhang, Z. / Reynolds, G.P. et al. | 2017
- S777
-
Regulation of cannabinoid CB1 and CB2 receptors and neuroprotective rapamycin (mTOR protein kinase) in major depression postmortem brainsSalort, G. / Hernández-Hernández, E. / García-Fuster, M.J. et al. | 2017
- S778
-
Attentional processing of emotional information in remitted recurrent major depressive disorder – preliminary results from the NEWPRIDE studyVan Kleef, R.S. / Nijmeijer, S.E. / Marsman, J.B.C. et al. | 2017
- S779
-
Heart rate variability, autonomic tone and depressive-like behavior differences in resilient and susceptible rats to social defeat stressMorais-Silva, G. / Costa-Ferreira, W. / Gomes-de-Souza, L. et al. | 2017
- S780
-
3β Methoxypregnenolone (MAP4343), a synthetic pregnenolone derivative, promotes neuronal and synaptic plasticity in vitroSchverer, M. / Leandri, J. / Amazit, L. et al. | 2017
- S781
-
The microtubule associated protein tau is essential for stress-driven depressive pathology and cognitive deficitsVaz-Silva, J. / Lopes, S. / Dioli, C. et al. | 2017
- S782
-
Cell-specific immune regulation and metabolic dysfunction in major depressive disorderHasselmann, H. / Taenzer, A. / Gamradt, S. et al. | 2017
- S783
-
Anti-depressant-like effects of cannabidiol and cannabidiolic acid in genetic rat models of depressionShbiro, L. / Hen-Shoval, D. / Hazut, N. et al. | 2017
- S784
-
Pharmacological prophylaxis of postpartum exacerbation in depressive and anxiety symptoms: a retrospective chart reviewUguz, F. / Subasi, E. / Dalboy, F. et al. | 2017
- S786
-
Toward a better characterisation and management of treatment-resistant depression in France through the network of expert centers (FondaMental)Yrondi, A. / El-Hage, W. / Charpeaud, T. et al. | 2017
- S787
-
The role of rare copy number variants in depressionKendall, K. / Rees, E. / Jones, I. et al. | 2017
- S788
-
Effect of agomelatine and escitalopram on emotional experiences in outpatients suffering from major depressive disorderGoodwin, G. / Scott, E. / Reis De Oliveira, I. et al. | 2017
- S789
-
Association of depression with the 10-year risk of cardiovascular mortality in primary care population in LatviaIvanovs, R. / Kivite, A. / Mintale, I. et al. | 2017
- S790
-
Depression-Associated Cardiac Failure (DACFAIL)Menke, A. / Wurst, C. / Stonawski, S. et al. | 2017
- S792
-
Cannabis use among depressive people: a study about one hundred thirty-six outpatientsAmamou, B. / Fathallah, S. / Mhalla, A. et al. | 2017
- S793
-
GSK-3beta rs334558 is associated with severe insomnia in patients with major depressive episode, but not with remission after antidepressant treatmentCostemale-Lacoste, J.F. / El Asmar, K. / Colle, R. et al. | 2017
- S794
-
Cognitive performance in patients with major depressive disorder treated with vortioxetine compared with escitalopram and venlafaxineFernandez-Miranda, J.J. / Frias-Ortiz, D.F. / Diaz-Fernandez, S. et al. | 2017
- S795
-
Cognitive performance and 12-month clinical outcome in first-episode of depressionVicent-Gil, M. / Keymer-Gausset, A. / Carceller-Sindreu, M. et al. | 2017
- S796
-
A meta-analysis of dose escalation of antidepressant agents in major depressive disorderBartova, L. / Dold, M. / Rupprecht, R. et al. | 2017
- S797
-
Effects of vortioxetine on composite scores across objective cognitive tests: results from 2 clinical studies in adults with major depressive disorderLoft, H. / Jacobson, W. / Olsen, C.K. et al. | 2017
- S798
-
Cognition predicts psychosocial functioning and psychological treatment adherence in depressive disordersCostas, A. / Ramos Grille, I. / Garrido García, G. et al. | 2017
- S799
-
The relation between major depressive disorder and comorbid generalized anxiety disorder – results from a European multicenter, cross-sectional surveyDold, M. / Bartova, L. / Souery, D. et al. | 2017
- S800
-
Gene polymorphisms of enzymes biotransformation of xenobiotics in patients with depressive disordersLevchuk, L. / Losenkov, I.S. / Lebedeva, E.V. et al. | 2017
- S801
-
Cortical monoamine oxidase – a distribution in seasonal affective disorder compared to healthy controlsJames, G.M. / Seiger, R. / Spies, M. et al. | 2017
- S803
-
The relationship between chronotype and problematic drinking according to gender in mood disorderKong, J.Y. et al. | 2017
- S804
-
Early screening during pregnancy for maternal psychopathology reduced postpartum depressive symptoms and improved mother-infant attachmentPetri, E. / Bacci, O. / Palagini, L. et al. | 2017
- S805
-
Dynamic connectivity analysis of selective serotonin reuptake inhibitor effects, a pharmacological PET/MR studyGryglewski, G. / Hahn, A. / Berroterán-Infante, N. et al. | 2017
- S807
-
Efficacy of venlafaxine extended-release compared with placebo in major depressive disorder patients by severity of anxiety symptomsLyndon, G. / Prieto, R. / Wajsbrot, D. et al. | 2017
- S808
-
A real-world study on time-to-initiation and dose optimization of major depressive disorder treatment in the United StatesPrieto Lopez, R. / Yeh, Y. / Gao, X. et al. | 2017
- S809
-
Sleep quality in mothers with postpartum depression and maternity blues: a preliminary studyDel Matto, L. / Costoloni, G. / Caterini, C. et al. | 2017
- S811
-
Time perception and binge watching among medical students with depressive symptomsBoudali, M. / Hamza, M. / Halayem, S. et al. | 2017
- S812
-
Adjunctive antidepressants to mood stabilizers or atypical antipsychotics in bipolar depression and 1-year rehospitalization rates: a cohort studyShvartzman, Y. / Krivoy, A. / Valevski, A. et al. | 2017
- S814
-
Structural brain differences between psychotic and non-psychotic bipolar patientsEsposito, C.M. / Fumagalli, G. / Lanfranconi, S. et al. | 2017
- S815
-
Social cognition in bipolar disorder: exploring emotional intelligenceVaro, C. / Jimenez, E. / Solé, B. et al. | 2017
- S816
-
Bipolar type I and substance use disorders: safety, tolerability and effectiveness of asenapine adjunctive treatmentFernandez-Miranda, J.J. / Frias-Ortiz, D.F. / Diaz-Fernandez, S. et al. | 2017
- S817
-
Body mass index associates with measures of white matter integrity in bipolar disorderMazza, E. / Poletti, S. / Bolletini, I. et al. | 2017
- S818
-
Atherogenic index of plasma in manic, depressive and euthymic stages of bipolar disorderKaramustafalioglu, N. / Kalelioglu, T. / Unalan, P. et al. | 2017
- S819
-
Could lithium prevent the bipolar disorder brain atrophy?Hozer, F. / Sarrazin, S. / Mangin, J.F. et al. | 2017
- S820
-
The brain-gut axis profiles in patients with bipolar depression: a preliminary studyHu, S. / Lu, Q. / Lai, J. et al. | 2017
- S821
-
Neurotrophins, inflammation and oxidative damage as mediators of cognitive functioning in bipolar disorderMora, E. / Portella, M. / Pinol-Ripoll, G. et al. | 2017
- S822
-
Predicting functional impairment in bipolar disorder: a pilot study with a machine learning approachPinto, J.V. / Librenza-Garcia, D. / Baldez, D.P. et al. | 2017
- S823
-
Antipsychotic use in acute mania: a retrospective study in an affective disorder specialized unit in Lisbon, PortugalCoelho, I. / Gonçalves, F. / Aleixo, A. et al. | 2017
- S824
-
Benefits and harms of atypical antipsychotics in the treatment of bipolar depression: a systematic review and metaanalysisNosaka, T. / Hagi, K. / Pikalov, A. et al. | 2017
- S825
-
Lurasidone adjunctive to lithium or valproate in patients with bipolar I disorder: effectiveness of up to 20 weeks of treatmentPikalov, A. / Tsai, J. / Mao, Y. et al. | 2017
- S826
-
One-year course of illness and clinical management in a cohort of patients affected with schizoaffective and bipolar disordersMurru, A. / Verdolini, N. / Pacchiarotti, I. et al. | 2017
- S827
-
IL-6 levels in bipolar patients with manic episodeTorres-Suarez, T. / Ramirez-Bermudez, J. / Diaz, A. et al. | 2017
- S828
-
Recurrence and recovery in aripiprazole once-monthly maintenance treatment of bipolar I disorder: a blinded, placebo-controlled, randomised studySuch, P. / Calabrese, J.R. / Sanchez, R. et al. | 2017
- S829
-
Graph analysis of verbal fluency test discriminates between patients with bipolar disorder and healthy controlsMachalska, K. / Turek, A. / Chrobak, A.A. et al. | 2017
- S830
-
High prevalence of cesarean sections in women with bipolar disorderSolé, E. / Suárez-Jesús, J. / Torres, A. et al. | 2017
- S831
-
Lurasidone for the treatment of major depressive disorder with mixed features: do manic symptoms moderate treatment response?Pikalov, A. / Goldberg, J. / Siu, C. et al. | 2017
- S832
-
Possible links between antipsychotic dosage equivalency and clinical features in bipolar patientsNascimento, M. / Bacelar, F. / Nobre, A. et al. | 2017
- S833
-
Functional impairment in adult bipolar disorder with ADHDTorres, I. / Garriga, M. / Sole, B. et al. | 2017
- S834
-
Tract-based fractional anisotropy mediates the relationship between illness duration and cognitive performances in bipolar disorderMelloni, E.M.T. / Poletti, S. / Bollettini, I. et al. | 2017
- S835
-
The serum S100B as a potential marker in bipolar spectrum disorderKapelski, P. / Rajewska-Rager, A. / Dmitrzak-Weglarz, M. et al. | 2017
- S836
-
Potential genes behind the difference between bipolar I and bipolar II disorderShugol, M. / Popovic, D. / Fabbri, C. et al. | 2017
- S837
-
The impact of psycho-educational group program on drug attitude and global functioning of real patients with bipolar disorderAlba, L. / Pérez, E.J. / Santamaria, M. et al. | 2017
- S838
-
Predominant polarity in bipolar disorder – is there a genetic base?Popovic, D. / Sentissi, O. / Stukalina, Y. et al. | 2017
- S839
-
Bipolar disorder and white matter microstructure: ENIGMA bipolar disorder fractional anisotropy DTI resultsPauling, M. / Henry, C. / Sarrazin, S. et al. | 2017
- S840
-
The efficacy of vortioxetine in a major depression case and follow-up of pruritus adverse effectYelken, B. et al. | 2017
- S841
-
Methodological limitations of comparative effectiveness research on antidepressants: a simulation studyChevance, A. / Naudet, F. / Gaillard, R. et al. | 2017
- S843
-
Chronic stress exposure impairs GABAergic homeostasis in the hippocampus: restorative effect of the novel antipsychotic lurasidoneRiva, M.A. / Rossetti, A. / Paladini, M.S. et al. | 2017
- S844
-
Evaluation of inhaled loxapine treatment in psychiatric patients with acute agitationMendez Mareque, D.R. / Aller Labandeira, V. / Lopez Cortiña, A. et al. | 2017
- S845
-
The role of the combined treatment of fluoxetine and metformin in potentiating antidepressant efficacyPoggini, S. / Viglione, A. / Matte Bon, G. et al. | 2017
- S846
-
Sex differences should be considered in the administration of lithium carbonate to patients with metabolic syndromeYonezawa, H. / Nagamine, T. / Nakamura, K. et al. | 2017
- S847
-
Effectiveness and tolerability of vortioxetine for major depressive disorderRomero Guillena, S.L. / Plasencia Garcia de Diego, B.O. / Navarro, R. et al. | 2017
- S848
-
Sleep deprivation with sleep phase advance in treatment-resistant depression: biological features of efficacyDopierala, E. / Jasmska-Mikołajczyk, A. / Ferensztajn-Rochowiak, E. et al. | 2017
- S849
-
The impact of currently recommended antihypertensive therapy on depression and other psychometric parameters: a prospective pilot studyKorosi, B. / Laszlo, A. / Tabak, A. et al. | 2017
- S850
-
Use of benzodiazepines in relation to onset and duration of untreated illness in psychotic and affective disordersDe Carlo, V. / Grancini, B. / Vismara, M. et al. | 2017
- S851
-
Quetiapine – adjunctive treatment of major depressive disorder with anxiety symptomsBise, S. / Sulejmanpašić, G. / Begic, D. et al. | 2017
- S853
-
Efficacy of dialectical behavior therapy compared to supportive therapy in adolescents with suicidal behaviorSantamarina Pérez, P. / Romero Cela, S. / Méndez Blanco, I. et al. | 2017
- S854
-
Effectiveness of inhaled loxapine (IL) in agitated patients diagnosed with personality disorder (PD) – a first approachPatrizi, B. / Navarro Haro, M.V. / Gasol, M. et al. | 2017
- S855
-
Pharmacological treatments and risk of re-hospitalisation due to unipolar depression in a nationwide cohort of 123, 712 patientsTiihonen, J. / Tanskanen, A. / Hoti, F. et al. | 2017
- S856
-
SAGE-217 in subjects with major depressive disorder: efficacy and safety results from open-label Part A of a phase 2A studyGunduz-Bruce, H. / Riesenberg, R. / Sankoh, A. et al. | 2017
- S857
-
Intravenous sodium valproate for the treatment of mixed symptoms in patients with bipolar disorder: a pilot studyAmodeo, G. / Olivola, M. / Fagiolini, A. et al. | 2017
- S858
-
Could cognitive remediation therapy increase psychological treatment adherence in depression disorders? The role of cognitive impairment (pilot study)Costas, A. / Ramos Grille, I. / Garrido García, G. et al. | 2017
- S859
-
Escitalopram versus duloxetine in acute treatment of major depressive disorder: a meta-analysis and systematic reviewManeeton, B. / Maneeton, N. / Woottiluk, P. et al. | 2017
- S860
-
Switching to vortioxetine from a selective serotonin reuptake inhibitor in patients with major depression in remission: focus on tolerabilityScarpellini, P. / Cerù, A. et al. | 2017
- S861
-
Intravenous clomipramine for treatment resistant depressionTrusso, M.A. / Baldini, I. / Fagiolini, A. et al. | 2017
- S862
-
Sex and interaction of CYP1A2 *1F/*1F genotype with smoking impact mirtazapine pharmacokinetics: a population pharmacokinetic analysisMadia, P. / Bies, R. / Pollock, B. et al. | 2017
- S863
-
Efficacy, safety, and tolerability of vortioxetine in the treatment of mood disordersTomassini, L. / Perrini, F. / Cuomo, I. et al. | 2017
- S865
-
Effects of adjunctive aripiprazole in patients with major depressive disorder with inadequate response to standard antidepressant therapyLee, J.S. / Kim, S.G. et al. | 2017
- S866
-
Safety and efficacy of ketamine infusion in treatment-resistant depression with multiple medical comorbidities: a case reportNakahira, C. / Steglich, M.S. / Ferreira, M.B. et al. | 2017
- S867
-
Effect of long-term valproate treatment on bone metabolism in patients with bipolar disorder: a pilot studyCuomo, A. / Costoloni, G. / Goracci, A. et al. | 2017
- S868
-
SSRI outcome depends on the environment: citalopram amplifies the influence of sociodemographic characteristics on mood in the STAR*D studyViglione, A. / Poggini, S. / Matte Bon, G. et al. | 2017
- S869
-
Net effect of serotonin reuptake inhibitors on suicidality in depression is beneficial rather than harmful already during the first week of treatmentNäslund, J. / Hieronymus, F. / Lisinski, A. et al. | 2017
- S870
-
Do SSRIs cause an initial increase in anxiety in depressed patients participating in placebo-controlled trials?Näslund, J. / Hieronymus, F. / Emilsson, J.F. et al. | 2017
- S871
-
Longitudinal investigation of subjective and objective cognitive side effects of electroconvulsive therapy – a pilot studyPetersen, J.Z. / Jørgensen, M.B. / Jensen, H.M. et al. | 2017
- S872
-
Comorbidity of depression and panic disorder affects suicide attempts in patients with mood disordersLiaugaudaite, V. / Podlipskyte, A. / Mickuviene, N. et al. | 2017
- S873
-
Clinical and genetic risk factors associated with suicidality in Korean patients with mood disordersKim, S.I. / Choi, H.Y. / Lim, W.J. et al. | 2017
- S874
-
Theory of mind and depersonalization in borderline personality disorderRomero Guillena, S.L. / Gotor Sanchez-Luengo, F. / Plasencia Garcia de Diego, B.O. et al. | 2017
- S875
-
Suicide ideation, anger and impulsiveness in chronic pain patients before and after pain relief: an observational studyMancini, V. / Marini, S. / Lalli, V. et al. | 2017
- S876
-
Is aggression a missed bipolar diagnostic feature in mixed depression?Verdolini, N. / Perugi, G. / Samalin, L. et al. | 2017
- S877
-
Effects of lithium on metabolic parameters and clinical response: a retrospective analysis of 820 mood disorder patientsPinna, M. / Manchia, M. / Visioli, C. et al. | 2017
- S878
-
Mania associated with digoxin: case description and literature reviewZuñiga-Costa, R. / Yelmo-Cruz, S. / Diaz-Melian, D. et al. | 2017
- S879
-
Mediterranean diet and moodDe Vries, E. / Van Schrojenstein Lantman, M. / Hoebregts, V. et al. | 2017
- S881
-
Toxoplasma gondii seroprevalence in a cohort of Italian psychiatric inpatients with mood or psychotic disorders: a preliminary communicationDel Grande, C. / Schiavi, E. / Masci, I. et al. | 2017
- S882
-
Depression symptoms and obstructive sleep apnea in coronary artery disease patientsJuskiene, A. / Varoneckas, G. / Podlipskyte, A. et al. | 2017
- S883
-
Depressive symptoms in elderly indigenous people of the Xukuru do Ororuba ethinic group, BrazilPetribu, K. / Lima, F. / Brotto, S. et al. | 2017
- S885
-
Polygenic risk profile score increases schizophrenia liability mostly through cognition pathways: mathematical causation models with polygenic riskToulopoulou, T. / Zhang, X. / Cherny, S. et al. | 2017
- S886
-
Abnormal visual scanning during reality evaluation and its relationship to magical ideation in schizophreniaLee, J.S. / Kim, M.W. / Kim, J.J. et al. | 2017
- S887
-
Disrupting protein-protein interactions of neuronal nitric oxide synthase: implications in schizophrenia-related behavioursCandemir, E. / Fattakhov, N. / Frerichs, V. et al. | 2017
- S888
-
Enhanced evaluative fear learning in delusion-pronenessLouzolo, A. / Ingvar, M. / Olsson, A. et al. | 2017
- S889
-
The effect of genetic variant of the ANKK1 gene with cannabis misuse in incipient psychotic patients: a controlled studySanchez-Gistau, V. / Arranz, S. / Sole, M. et al. | 2017
- S890
-
Sex differences in a neurodevelopmental animal model of schizophrenia: focus on white matter structures and myelinStark, T. / Drazanova, E. / Vaskovicova, N. et al. | 2017
- S891
-
Lactational immune activation model: from trans-diagnostic risk to trans-diagnostic preventionArad, M. / Piontkewitz, Y. / Albelda, N. et al. | 2017
- S892
-
Maintenance to win: prospective observational study of extended-release injectable aripiprazole for maintenance therapy in psychotic outpatientsDe La Gandara, J.J. / Mayo, S. et al. | 2017
- S893
-
The effects of nutriose-glucomannan-antioxidant complex on the parameters of the metabolic syndrome in the schizophrenia patients treated with olanzapineDjokic, G.M. / Djordjevic, V. / Agic, A. et al. | 2017
- S894
-
Blood biomarkers predict the cognitive effects of aripiprazole in patients with acute schizophreniaHori, H.H. / Yoshimura, R.Y. / Katsuki, A.K. et al. | 2017
- S896
-
Schizophrenia and adjunctive aripiprazole for antipsychotic-induced sexual dysfunctionSulejmanpasic-Arslanagic, G. / Bise, S. et al. | 2017
- S897
-
Cognitive effects of polypharmacy in psychotic disorders – less is moreAndric Petrovic, S. / Jerotic, S. / Ristic, I. et al. | 2017
- S898
-
A systematic review of methods for the assessment of antipsychotics adherence: focus on delusional disorderGonzalez Rodriguez, A. / Estrada, F. / Monreal, J.A. et al. | 2017
- S899
-
The association between serum levels of brain-derived neurotrophic factor and cognitive impairment in chronic elderly schizophrenia inpatientsAtake, K. / Nakamurra, T. / Ueda, N. et al. | 2017
- S900
-
Early-onset inguinal hernia as risk factor for schizophrenia or related psychosis: a nationwide register-based cohort studyMelkersson, K. / Wernroth, L. et al. | 2017
- S901
-
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophreniaVignapiano, A. / Koenig, T. / Mucci, A. et al. | 2017
- S902
-
Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomainsLaszlovszky, I. / Barabassy, A. / Szatmári, B. et al. | 2017
- S903
-
Demographic and pharmacological profile of inpatients treated with intramuscular paliperidone palmitate in a psychiatric unitGonzález Garrido, S. / Riesgo Arias, M. / Banda Moruno, J. et al. | 2017
- S904
-
Non organic hallucinatory behaviour and neurocognitive deterioration in patients with functional psychosesOlteanu, V.A. / Dehelean, L. / Romosan, A. et al. | 2017
- S905
-
Risk factors for low bone mineral density in patients taking antipsychotics for psychosisYoo, T. / Kim, S.W. / Jhon, M. et al. | 2017
- S907
-
Evaluation of olfactory function in patients with recent onset psychosis and at-risk mental state in an early intervention programArranz, S. / Izquierdo, E. / Cabezas, A. et al. | 2017
- S908
-
Healthcare resource use in schizophrenia sufferers – findings from the EuroSC cohortMillier, A. / Toumi, M. / Horváth, M. et al. | 2017
- S909
-
Health-related quality of life in outpatients with schizophrenia: what determines changes over time and how to measure themDomenech, C. / Altamura, C. / Bernasconi, C. et al. | 2017
- S910
-
Hand functions in patients with schizophrenia: comparison with bipolar disorder and healthy subjectsHacioglu Yildirim, M. / Yildirim, E.A. / Carpar, E. et al. | 2017
- S911
-
Obstetric complications and cognitive function in schizophreniaMezquida, G. / Fernandez-Egea, E. / Treen, D. et al. | 2017
- S913
-
Two-year follow-up of patients with a first psychotic episode: comparison between affective and non-affective psychoses and predictors of functioningTorrent, C. / Reinares, M. / Martinez-Aran, A. et al. | 2017
- S914
-
Speech graph analysis of verbal fluency tests distinguish between patients with schizophrenia and healthy controlsTurek, A. / Machalska, K. / Chrobak, A.A. et al. | 2017
- S915
-
Comparison of serum tumor necrosis factor-like weak inducer of apoptosis levels in patients with schizophrenia and healthy control subjectsOzkal, U. / Gultekin, G. / Incir, S. et al. | 2017
- S917
-
Validation of the international classification of functioning, disability and health core set for schizophrenia from the perspective of psychologistsNuño, L. / Barrios, M. / Rojo, E. et al. | 2017
- S918
-
Break and recovery points of fusion differentiate schizophrenia from bipolar disorder patientsChrobak, A. / Abramowicz, M. / Perdziak, M. et al. | 2017
- S919
-
CB1-5-HT2A heteromers and neurological soft signs in schizophrenia patients: human studies in pro-neurons of the olfactory epitheliumGalindo, L. / Robledo, P. / Moreno, E. et al. | 2017
- S920
-
Nicotinic alpha7 receptor agonist and modulators improved social but not sensorimotor deficits on subchronic MK-801 model of schizophrenia in ratsUnal, G. / Zortul, H. / Hazar-Yavuz, A. et al. | 2017
- S921
-
Nigella sativa extract improved sensorimotor gating deficit on acute ketamine model of schizophrenia in ratsUnal, G. / Keles, R. / Taskin, T. et al. | 2017
- S922
-
Pre-clinical evaluation of two novel benzamides, LB-102 and 103, for the treatment of schizophreniaNeill, J. / Grayson, B. / Podda, G. et al. | 2017
- S923
-
Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophreniaOsmanova, D. / Boiko, A.S. / Fedorenko, O.Y. et al. | 2017
- S924
-
Long-term antipsychotic treatment and corpus callosum volume: an MRI study in patients with schizophreniaTrehout, M. / Leroux, E. / Delcroix, N. et al. | 2017
- S925
-
Modulation of sub-chronic ketamine-induced locomotor sensitisation by midbrain dopamine neuron firingKokkinou, M. / Irvine, E.E. / Bonsall, D.R. et al. | 2017
- S926
-
Evolution of patients with paranoid schizophrenia treated with paliperidone injectionNechita, P. / Craciun, G. / Nechita, D.C. et al. | 2017
- S927
-
Follow-up 30 cases of patients treated with aripiprazole depot along 18 months continuation or discontinuationDe Jaime Ruiz, P. et al. | 2017
- S928
-
Pharmacological management of antipsychotic-induced obesity – a systematic literature reviewVasile, D. / Vasiliu, O. / Fainarea, A.F. et al. | 2017
- S929
-
Aripiprazole once-monthly long-acting injectable in schizophreniaPlasencia García de Diego, B.O. / Romero Guillena, S.L. / Gotor Sanchez-Luengo, F. et al. | 2017
- S930
-
E-medicine: a smartphone application to antipsychotic switchBottaï, T. / Dassa, D. / Raymondet, P. et al. | 2017
- S931
-
Antipsychotic treatment in hospitalized patients with schizophrenia and with the occurence of aggressive behavior (2-years review)Zelman, M. / Godinova, S. / Zholob, M. et al. | 2017
- S932
-
Cariprazine specificity profile in the treatment of acute schizophrenia: a meta-analysis and meta-regression of randomized-controlled trialsCorponi, F. / Serretti, A. / Montgomery, S. et al. | 2017
- S933
-
Schizophrenia, hospitalisations and antipsychotic treatment: analysing LAI patterns in a brief hospitalisation unitPascual, J.M. / Mongil San Juan, J.M. / Rodriguez Gomez, C. et al. | 2017
- S934
-
Inflammatory processes and schizophrenia: evidence from a twin studyStassen, H.H. / Braun, S. / Bridler, R. et al. | 2017
- S935
-
Sustained remission with cariprazine treatment: post hoc analysis of a randomized, double-blind, schizophrenia relapse prevention trialCorrell, C.U. / Potkin, S.G. / Durgam, S. et al. | 2017
- S936
-
Efficacy of cariprazine in subgroups of bipolar patients with manic episodes, mixed episodes, and with or without psychotic symptomsVieta, E. / Durgam, S. / Lu, K. et al. | 2017
- S937
-
Antipsychotics and mortality in a nationwide cohort of 29, 823 patients with schizophreniaTiihonen, J. / Mittendorfer-Rutz, E. / Alexanderson, K. et al. | 2017
- S938
-
Long-term complex therapy of schizophrenia with paliperidone palmitate in combination with psychosocial interventions in outpatient settingsSavelyev, A. / Korman, T. / Gritsevskaya, T. et al. | 2017
- S940
-
The validity and sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyOstergaard, S.D. / Foldager, L. / Mors, O. et al. | 2017
- S942
-
Sustained remission and symptom stability in patients with schizophrenia receiving aripiprazole once-monthly: a 52-week, open-label, maintenance studyPeters-Strickland, T. / Jin, N. / Such, P. et al. | 2017
- S943
-
Inflammatory markers and clinical outcome in treatment resistant schizophrenia inpatients treated with clozapineKalter, E. / Horovitz, T. / Shlosberg, D. et al. | 2017
- S944
-
Patient reported outcomes from schizophrenia patients treated with paliperidone palmitate 1-monthly for at least 6 months (picture study)Vega, M. / Arqués, S. / Herrera, B. et al. | 2017
- S945
-
Potential biomarkers of tardive dyskinesia: a multiplex analysis of blood serumBoiko, A.S. / Kornetova, E.G. / Ivanova, S.A. et al. | 2017
- S946
-
Antidepressant augmentation of antipsychotics in schizophrenia: a systematic review, meta-analysis and metaregression analysisGalling, B. / Correll, C.U. et al. | 2017
- S947
-
Evenamide, a voltage-gated sodium channel blocker in the treatment of schizophrenia: results from a placebo-controlled studyAnand, R. / Forrest, E.C. / Hartman, R.D. et al. | 2017
- S948
-
Deep brain stimulation in schizophrenia: a randomized pilot study testing anterior cingulated cortex vs. nucleus accumbens targetsRoldán, A. / Sarró, S. / Rabella, M. et al. | 2017
- S949
-
Redox dysregulation in schizophrenia pathophysiology: add-on trial with N-acetyl-cysteine (NAC) in early psychosis patientsFournier, M. / Conus, P. / Seidman, L. et al. | 2017
- S950
-
Subset analyses by race of a phase 2 study of TAK-063 in subjects with acute exacerbations of psychotic symptomsMahableshwarkar, A.R. / McCue, M. / Dong, X. et al. | 2017
- S951
-
Are there differences in the antipsychotic load between deficit and non-deficit syndrome in first-episode schizophrenia?López-Díaz, A. / Lara, I. / Lorenzo-Herrero, P. et al. | 2017
- S952
-
Aripiprazole LAI vs. paliperidone LAI in inpatients with psychosis comorbid with substance use disorder: clinical and QoL effects at 1-year follow-upCuomo, I. / Kotzalidis, G.D. / De Persis, S. et al. | 2017
- S953
-
Safety and tolerability of brexpiprazole in adults with schizophrenia: results of an open-label, long-term studyWeiss, C. / Forbes, A. / Hobart, M. et al. | 2017
- S954
-
Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966Hulkko, A. / Murray, G.K. / Moilanen, J. et al. | 2017
- S955
-
Theta burst stimulation on medial prefrontal cortex in schizophrenia patients with impaired social cognition: a pilot 1H-MRS studyBriend, F. / Nathou, C. / Kauffmann, F. et al. | 2017
- S957
-
Effect of brexpiprazole on prolactin: an analysis of short- and long-term trials in schizophreniaIvkovic, J. / Lindsten, A. / George, V. et al. | 2017
- S958
-
Effect of dopamine D2 receptor and serotonin 2A receptor gene polymorphisms on response to risperidone in schizophreniaCharanraj Goud, A. / Shewade, D.G. / Raj Kumar, R. et al. | 2017
- S960
-
Hospitalisation rate in individuals with schizophrenia treated with long acting injectable atypical antipsychotics in Latin America – the REALAI studyRodriguez, R. / Palmeira, L. / Ramos, J. et al. | 2017
- S962
-
Effects of sertindole on EEG activity in patients with schizophreniaDebicka, M. / Kroc, A. / Wierzbicka, A. et al. | 2017
- S963
-
Effect of omega-3 supplementation during pregnancy and in offspring adolescence: an animal model of schizophrenia induced by poly(I:C)Rosa, E.D. / Géa, L.P. / Panizzutti, B.S. et al. | 2017
- S964
-
Proteomic profiling changes induced by physical activity in patients with schizophreniaVallejo-Curto, M. / Rivera-Baltanás, T. / Blanco-Formoso, M. et al. | 2017
- S965
-
The involvement of GABAB receptors in antipsychotic-like effects of positive allosteric modulator of muscarinic acetylcholine M4 receptorsCiešlik, P. / Woźniak, M. / Pilc, A. et al. | 2017
- S966
-
Does genetics of obesity overlap with pharmacogenetics of antipsychotic induced weight gain? A molecular pathway analysisCorfitsen, H. / Krantz, B. / Drago, A. et al. | 2017
- S967
-
Epigenetic signature of early trauma: differences in the FKBP5 DNA methylation levels among psychotic patients, their healthy siblings and controlsMihaljevic, M. / Franic, D. / Soldatovic, I. et al. | 2017
- S968
-
Compliance with psychotropic medications – a patient's perspectiveVidenova, V. / Manuseva, N. / Stefanovski, B. et al. | 2017
- S969
-
Factors predicting personal and social performance in patients with schizophreniaKim, S.H. / Yi, J.S. / Kim, J.J. et al. | 2017
- S970
-
Sleep disturbance in schizophrenia inpatients and related factorsKim, S.K. / Jung, B.J. et al. | 2017
- S971
-
The report on current state and effectiveness of occupational therapy with mentally disabled people in KoreaLee, S.M. / Chung, H.Y. / Hong, M. et al. | 2017
- S973
-
The relation between negative symptoms and reward alterations before and after antipsychotic treatment in first episode patients with schizophreniaNielsen, M.Ø. / Wulff, S. / Rostrup, E. et al. | 2017
- S974
-
Interpersonal problems and personality disorder in Korean criminal offenders with schizophreniaChee, I.S. / Kim, Y. / Kwon, J. et al. | 2017
- S975
-
Psychiatric disorders in child and adolescent offspring of patients with schizophrenia and bipolar disorder: a four-year follow-up studyDe la Serna, E. / Sugranyes, G. / Romero, S. et al. | 2017
- S976
-
Do treatment goals impact treatment decisions among people recently diagnosed with schizophrenia?Bridges, J.F. / Beusterien, K. / Heres, S. et al. | 2017
- S977
-
Reward alterations in antipsychotic naive first episode psychosis before and after treatment with a partial dopamine agonistTangmose, K. / Nielsen, M.Ø. / Sigvard, A. et al. | 2017
- S978
-
Metabolic syndrome and schizophrenia: the role of substance abuseFerreira, C. / Castanheira, L. / Ferreira, L. et al. | 2017
- S979
-
Genetic variants within key nodes of the cascade of antipsychotic mechanisms: effects on treatment response and schizophrenia psychopathologyPorcelli, S. / Calabrò, M. / Crisafulli, C. et al. | 2017
- S980
-
Subjective interview quality metrics predict scoring performance in the administration of the PANSSNegash, S. / Echevarria, B. / Stein, L. et al. | 2017
- S981
-
Within person variance as a quality metric – an exploratory analysis identifying outlier sites in schizophrenia clinical trialsKott, A. / Wang, X. / Sachs, G. et al. | 2017
- S982
-
Social anxiety disorder among applicants to the psychiatry Master's Degree program in MalaysiaAzhar, F.L. / Gill, J.S. / Sulaiman, A.H. et al. | 2017
- S983
-
Neural substrates of fear conditioning are modulated by GLRB allelic variation: converging evidence from an independent replicationLueken, U. / Kuhn, M. / Yang, Y. et al. | 2017
- S984
-
Chronic social defeat stress: impact on sleep in susceptible miceHenderson, F. / Vialou, V. / El Mestikawy, S. et al. | 2017
- S985
-
Hypothalamic miR-132-3p changes in response to intracerebroventricular oxytocin: relevance for anxiety- and fear-related behaviourBludau, A. / Menon, R. / Meister, G. et al. | 2017
- S986
-
Circulating microRNAs as potential biomarkers of differential susceptibility to traumatic stressDe Nijs, L. / Krauskopf, J. / Snijders, C. et al. | 2017
- S987
-
Fibroblast growth factor-antisense overexpression in medial prefrontal cortex regulates anxiety-like behaviour in ratsEren Kocak, E. / Hokelekli, F.O. / Karatas-Kursun, H. et al. | 2017
- S988
-
Administration of para-chlorophenylalanine reduces both expression and acquisition of context-conditioned fearHagsäter, S.M. / Johansson, E. / Pettersson, R. et al. | 2017
- S989
-
From uncertainty to checking: the role of metacognitive monitoring in obsessive compulsive disorder (OCD)Baptista, A. / N'Diaye, K. / Mallet, L. et al. | 2017
- S990
-
Altered functional connectivity of the subthalamus and the bed nucleus of the stria terminalis in obsessive-compulsive disorderCano Català, M. / Alonso, P. / Martínez-Zalacaín, I. et al. | 2017
- S991
-
Prescribing practices in obsessive-compulsive disorder in ItalyMarazziti, D. / Mucci, F. / Tundo, A. et al. | 2017
- S992
-
Anxiety associated with a reduction of cardiovascular mortality risk in primary care population in LatviaIvanovs, R. / Kivite, A. / Mintale, I. et al. | 2017
- S993
-
Identification and comparison of workplace stressors in different profiles of health care workers in primary and secondary community health careTrifunovic, N. / Dzubur Kulenovic, A. / Jatic, Z. et al. | 2017
- S994
-
The 'Body keeps the score' revisited: changes in lipid levels and Coronary Disease risk in veterans suffering from chronic PTSDDzubur Kulenovic, A. et al. | 2017
- S995
-
Functional connectivity of premotor, sensorimotor and insular regions in obsessive-compulsive disorder patients with and without sensory phenomenaDel Cerro, I. / Subirà, M. / Alonso, P. et al. | 2017
- S996
-
Secondary traumatisation and some related outcomes in firefightersBastug, G. / Ergul Topcu, A. / Ergun, O.F. et al. | 2017
- S997
-
The prefrontal-amygdala circuit in trait anxiety and generalized anxiety disorder. Testing the boundaries between healthy and pathological worriesPorta, D. / Via, E. / Goldberg, X. et al. | 2017
- S998
-
Will early intervention with SSRI versus benzodiazepines reduce the risk of developing posttraumatic stress disorder?Frankova, I. et al. | 2017
- S999
-
Distinct contributions of obsessive and compulsive symptoms for whole-brain functional connectivity in obsessive-compulsive disorderMoreira, P. / Marques, P. / Magalhaes, R. et al. | 2017
- S1000
-
Common neurotransmission recruited in (R, S)-ketamine and (2R, 6R)-hydroxynorketamine-induced sustained antidepressant-like effectsPham, T.H. / Defaix, C. / Xu, X. et al. | 2017
- S1001
-
Reducing fear extinction deficits in a 5-HT2C receptor editing model of post-traumatic stress disordersRegue, M. / Martin, V. / Lanfumey, L. et al. | 2017
- S1002
-
Prevalence of anxiety and depressive symptoms in a Canadian medical cannabis use cohortVan Ameringen, M. / Simpson, W. / Turna, J. et al. | 2017
- S1003
-
Evaluating self-knowledge and self-control workshops for patients with anxiety disordersRomero Guillena, S.L. / Garcia Salguero, M. / Jimenez Hernandez, J.H. et al. | 2017
- S1004
-
Augmentation of serotonin reuptake inhibitors with antipsychotic drugs in treatment-resistant obsessive-compulsive disorder: a meta-analysisDold, M. / Aigner, M. / Kasper, S. et al. | 2017
- S1005
-
Neural plasticity following cognitive-behavioral therapy in panic disorder – the impact of comorbid depressionKunas, S.L. / Yang, Y. / Straube, B. et al. | 2017
- S1006
-
The effect of early maladaptive schema on the treatment outcomes of cognitive-behavioural group therapy for panic disorderLee, S.J. / Won, S.H. / Chang, S.M. et al. | 2017
- S1008
-
Panicolytic effect of naltrexone: a randomised clinical trialFranceschi Biagioni, A. / Freire, R.C.R. / Nardi, A.G. et al. | 2017
- S1009
-
Effects of escitalopram challenge on white matter diffusion in obsessive-compulsive disorder and healthy controlsRoos, A. / Fouche, J. / Stein, D. et al. | 2017
- S1010
-
Brain incorporation of different polyunsaturated fatty acids ratio and anxiety-like symptoms development in young rats supplemented with omega-3/-6Kuhn, F.T. / Bürger, M.E. / Dias, V.T. et al. | 2017
- S1012
-
MicroRNA signature associated with enhanced vulnerability to develop psychiatric disorders: dissecting the mechanisms by using an in vitro modelCattane, N. / Mariani, N. / Pariante, C. et al. | 2017
- S1013
-
Chronic stress targets adult hippocampal neurogenesis preferentially in the suprapyramidal blade of rat dorsal dentate gyrusAlves, N.D. / Patrício, P. / Correia, J.S. et al. | 2017
- S1014
-
Cold pressor pain in body focused repetitive behaviour disordersRedden, S.A. / Chamberlain, S.R. / Grant, J.E. et al. | 2017
- S1015
-
Sex-dependent differences in oxytocin receptor gene methylation between posttraumatic stress disorder patients and trauma-exposed healthy controlsNawijn, L. / Krzyzewska, I. / Van Zuiden, M. et al. | 2017
- S1016
-
Sucrose intake test as a tool to study vulnerability/resilience towards acute stressSala, N. / Musazzi, L. / Tornese, P. et al. | 2017
- S1017
-
Brain structural correlates of subclinical obsessive-compulsive symptoms in healthy childrenSunol, M. / Contreras-Rodríguez, O. / Macià, D. et al. | 2017
- S1018
-
Alcohol abuse in subjects developing or not post-traumatic stress disorder after trauma exposureFiori, F. / Vellante, F. / Sarchione, F. et al. | 2017
- S1019
-
Fragmented REM sleep contributes to slow dissolving of emotional distress and hyperarousal in insomniaWassing, R. / Schalkwijk, F. / Van Someren, E.J. et al. | 2017
- S1020
-
Cardiovascular reactions to psychosocial stress, Type D personality and trait anxiety in patients with coronary artery diseaseGecaite, J. / Burkauskas, J. / Brozaitiene, J. et al. | 2017
- S1022
-
Ghrelin mimetic MK-677 alleviates amyloid beta-related pathology in 5XFAD mice, an animal model of Alzheimer's diseaseLee, S.M. / Hong, M.H. / Chung, H.Y. et al. | 2017
- S1023
-
Effects of dimethyl fumarate treatment on adult neurogenesis in the streptozotocin-induced rat model of sporadic Alzheimer's diseaseKurowska, E. / Majkutewicz, I. / Podlacha, M. et al. | 2017
- S1024
-
The PDE4-inhibitor roflumilast improves memory: findings from a translational perspectiveVan Duinen, M.A. / Sambeth, A. / Heckman, P.R.A. et al. | 2017
- S1026
-
Cognitive function associated with depression in patients with Alzheimer's disease and the elderly without dementiaKim, D.H. / Moon, Y. / Yoon, K. et al. | 2017
- S1027
-
Cognitive impairment and plasma phoenixin levelGultekin, G. / Batun, G.C. / Yuruyen, M. et al. | 2017
- S1029
-
Antidepressants and anxiolytics in cognitive impairment: conclusions of a longitudinal studyCenalmor Aparicio, C. / Cabello de Alba, S.M. / Crespo Generelo, T. et al. | 2017
- S1030
-
Classification and prediction of neuropathological change of Alzheimer's disease using machine learning and MRIKautzky, A. / Seiger, R. / Hahn, A. et al. | 2017
- S1031
-
Mitochondria-targeted antioxidant SkQ1 reduces the death of dopaminergic neurons in the model of Parkinson's disease in micePavshintcev, V. / Podshivalova, L. / Averina, O. et al. | 2017
- S1032
-
Genetic variants of SNCA, risk of Parkinson's disease and alpha-synuclein level in CD45+ blood cellsKulabukhova, D. / Garaeva, L.A. / Emelyanov, A.K. et al. | 2017
- S1033
-
Patient-specific and in vitro models for the analysis of late-onset Alzheimer's diseaseEhrhardt, T. / Jung, M. / Hartmann, C. et al. | 2017
- S1034
-
Behavioral impairments after intranasal administration of alpha-synuclein oligomers in aged miceKalinin, I. / Solovieva, O.A. / Proshin, A.T. et al. | 2017
- S1035
-
The statistical analysis of the changes of the depressive mental states of Japanese patients with subacute myelo-optico neuropathyKonishi, T. et al. | 2017
- S1036
-
Myasthenia gravis: co-morbid psychiatric disorders and use of psychotropic medicationMachado, C. / Almeida, B. / Fragoeiro, C. et al. | 2017
- S1037
-
P300 parameters as markers for early stages of subcortical vascular neurocognitive disorder and treatment efficacyLevada, O.A. / Cherednichenko, N.V. / Troyan, A.S. et al. | 2017
- S1038
-
Ten-day cognitive training program combined with transcranial direct current stimulation (tDCS) in stroke rehabilitation – a sham controlled studySzépfalusi, N. / Németh, V.L. / Vékony, T. et al. | 2017
- S1039
-
Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's diseaseIvanova, S.A. / Alifirova, V.M. / Freidin, M.B. et al. | 2017
- S1040
-
Antipsychotics without psychosis: exploratory study in Portuguese nursing homesFerreira, A.R. / Moreira, E. / Guedes, J. et al. | 2017
- S1041
-
Anterograde amnesia following a hanging attempt: a case reportGoren, Y. / Glik, A. / Steinmetz, A. et al. | 2017
- S1042
-
Psychopathology variables in neck-pain patientsHenry, M. / Henry-González, A.A. / Morera-Fumero, A. et al. | 2017
- S1043
-
The effect of melatonin and zinc on primary insomnia in elderly patientsHenry, M. / Henry-González, A.A. / Morera-Fumero, A. et al. | 2017
- S1044
-
Effects of chronic alcoholisation and ethanol withdrawal on expression of OX1R orexin brain receptors in ratsShabanov, P.D. / Sekste, E.A. / Airapetov, M.I. et al. | 2017
- S1045
-
Prenatal alcohol exposure disrupts dopamine-related gene expression in the rat midbrainRazumkina, E. / Nizharadze, M. / Anokhin, P. et al. | 2017
- S1046
-
Functional inactivation of accumbens disrupts context-induced reinstatement of alcohol seeking in ratsBianchi, P.C. / Leão, R.M. / Palombo, P. et al. | 2017
- S1047
-
Study of the effects of caffeinated/sugared energy drinks on ethanol craving, in ratsRomano, J.J. / Nassis, C.Z. / Petri, G. et al. | 2017
- S1048
-
Neural correlates of the anticipation of a sip of beer in young adult malesGroefsema, M.M. / Luijten, M. / Engels, R.C.M.E. et al. | 2017
- S1049
-
Association of gamma-glutamyl transferase (GGT) with risk of alcohol use behavioursKim, J.W. / Lee, B.C. / Choi, I.G. et al. | 2017
- S1051
-
The impact of positive and negative emotional states vs. comorbid depression or anxiety diagnoses on alcohol consumption in male and female alcoholicsKarpyak, V. / Geske, J.R. / Hall-Flavin, D.K. et al. | 2017
- S1054
-
A high working memory load preceding alcohol cue exposure, reduces the desire for alcohol in non-treatment seeking problem drinkersKaag, A.M. / Pattij, T. / De Vries, T.J. et al. | 2017
- S1055
-
Neuropsychological correlates of as-needed pharmacotherapy in alcohol dependence: double-blind placebo control study with the opioid antagonist nalmefeneGál, B.I. / Kilencz, T. / Albert, A. et al. | 2017
- S1056
-
Affective temperaments in alcohol dependence: influence of depressionGuldner, C. / Mohamed, M. / Bourdel, M.C. et al. | 2017
- S1057
-
Association between CACNA1C gene rs1034936 polymorphism and alcoholism in bipolar disorderMosheva, M. / Popovic, D. / Stukalin, Y. et al. | 2017
- S1058
-
The influence of co-administration of mephedrone and nicotine on anxiety- and memory-related behaviours and nicotine-induced sensitization in miceBiala, G. / Kaszubska, K. / Kruk-Slomka, M. et al. | 2017
- S1060
-
Combination of pregabalin with morphine: reinforcing and inhibiting effectsVashchinkina, E. / Vekovischeva, O. / Piippo, O. et al. | 2017
- S1061
-
The role of chronic stress on addictive vulnerability – focus on the nucleus accumbensLima, C. / Morgado, P. / Marques, F. et al. | 2017
- S1063
-
Impact of repeated administration of cocaine on the expression of genes involved in cholesterol metabolism in the rat brainAlsebaaly, J. / Rabbaa Khabbaz, L. / Dugast, E. et al. | 2017
- S1064
-
BDNF alterations in nucleus accumbens shell during morphine withdrawalGeoffroy, H. / Marie, N. / Noble, F. et al. | 2017
- S1064
-
Cue reactivity and opioid blockade in amphetamine dependence: a randomised, controlled fMRI studyGuterstam, J. / Jayaram Lindström, N. / Berrebi, J. et al. | 2017
- S1066
-
Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration – a translational studyJayaram-Lindström, N. et al. | 2017
- S1068
-
Substance-induced psychotic disorders in an acute psychiatric inpatient unitFernandez-Quintana, A. / Quiroga-Fernández, C. / Novo-Ponte, A. et al. | 2017
- S1070
-
SLC6A2 genotype variation and the modulatory effects of atomoxetine on inhibitory control in individuals with and without cocaine use disorderLe, A.N. / Ziauddeen, H. / Fernandez-Egea, E. et al. | 2017
- S1071
-
Demographic and clinical profile of cannabis users in SingaporePezhummoottil Vasudevan Nair, A. / Guo Zheng, T. / Kumar, D. et al. | 2017
- S1073
-
The effect of methylphenidate on executive functioning in patients with co-morbid ADHD and stimulant use disorderBrynte, C. / Konstenius, M. / Jayaram-Lindström, N. et al. | 2017
- S1074
-
Alcohol use disorders in patients with cannabis dependence seeking treatmentDervaux, A. / Bourdel, M. / Krebs, M. et al. | 2017
- S1075
-
Opioid maintenance therapy for the treatment of opioid use disorders in outpatients with or without schizophreniaBouton, J.F. / Laqueille, X. / Bourdel, M.C. et al. | 2017
- S1076
-
Six-month follow up of patients with dual pathology in a community mental health settingNovo Ponte, A. / Fernandez Quintana, A. / Quiroga Fernandez, C. et al. | 2017
- S1077
-
Can cytokines serve as biomarkers of current cocaine use?Milpied, T. / Vorspan, F. / Etain, B. et al. | 2017
- S1079
-
Predicting adolescent smoking using fMRI – a possible predisposing role for inhibitory control and reward processing in addictive behavioursJollans, L. / Whelan, R. et al. | 2017
- S1080
-
Neural activity in response to smoking-related and neutral pictures in three different states in smokersSteinegger, C. / Engeli, E. / Kirschner, M. et al. | 2017
- S1081
-
Relationship between cyberaddiction and social anxiety among students in medicine: about 188 studentsAmamou, B. / Ben Hawala, A. / Mhalla, A. et al. | 2017
- S1082
-
Is impulsivity the only trait that matters in addictive behaviour?Crisan, G. / Manea, M.M. / Miron, A. et al. | 2017
- S1083
-
Why do addicted people participate in research?Morán-Sánchez, I. / Luna, A. / Rodríguez-Hernández, A. et al. | 2017
- S1084
-
Higher emotional eating scores before a nutritional treatment in patients with obesity moderates the development of binge eating disorderMallardo, L. / Santangelo, A. / Mannucci, E. et al. | 2017
- S1085
-
Sexual addiction in Tunisia: an exploration of prevalence, socio-demographic characteristics and self esteemMissaoui, C. / Amamou, B. / Mhalla, A. et al. | 2017
- S1086
-
Relation between food addiction and nutritional status in patients candidates for bariatric surgeryFuentes, M. / Gabler, G. / Silva, J. et al. | 2017